Proton teletherapy of uveal melanoma

International Ophthalmology Clinics

Volumn 46, Issue 1, 2006, Pages 41-49

  Char, Devron H ^a   Phillips, Theodore ^b   Daftari, Inder ^c  

^a Tumori Foundation   (United States)

^b University of California San Francisco ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIUM; IODINE; IODINE 125; PROTON;

ANTERIOR EYE SEGMENT; ARTICLE; ASPIRATION BIOPSY; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; HELIUM ION RADIATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ENERGY TRANSFER; MORBIDITY; NEOVASCULAR GLAUCOMA; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROTON RADIATION; PROTON THERAPY; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RETINA MACULOPATHY; TELETHERAPY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR NECROSIS; UVEA MELANOMA; VISION; MELANOMA; METHODOLOGY; REVIEW; TELERADIOLOGY; UVEA TUMOR;

HUMANS; MELANOMA; PROTONS; TELERADIOLOGY; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 33644876975     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000195853.85581.c0     Document Type: Article

References (25)

1. Char DH. Therapeutic options in uveal melanoma. Am J Ophthalmol. 1984;98:796-799.
2. Char DH, Quivey JM, Castro J, et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma: a prospective randomized dynamically balanced trial. Ophthalmology. 1993;100:1547-1554.
3. Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125:81-89.
4. Gragoudas E, Li W, Goitein M, et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002;120:1665-1671.
5. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001;51:138-147.
6. Hungerford JL. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Exp Ophthalmol. 2003;31:8-13.
7. Desjardins L, Lumbroso L, Levy C, et al. Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates. J Fr Ophtalmol. 2003;23:269-276.
8. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanomas. Ophthalmology. 1999;106:1579-1587.
9. Harbour JW, Meredith TA, Thompson PA, et al. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology. 2003;110:2207-2214.
10. Char DH, Miller TR, Crawford JB. Uveal tumour resection. Br J Ophthalmol. 2001;85:1213-1219.
11. Kivela T, Puusaari I, Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study. Ophthalmology. 2003;110:2235-2244.
12. Bechrakis NE, Bornfeld N, Zoller I, et al. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology. 2002;109:1855-1861.
13. Char DH, Kroll SM, Miller T, et al. Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol. 1996;122:509-513.
14. Kindy-Degnan NA, Char DH, Castro JR, et al. Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Am J Ophthalmol. 1989;107:114-120.
15. Puusaari I, Heikkonen J, Summanen P, et al. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology. 2003;110:2223-2234.
16. Kim MK, Char DH, Castro JL, et al. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology. 1986;93:189-193.
17. Meecham WJ, Char DH, Kroll S, et al. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch Ophthalmol. 1994;112:197-203.
18. Daftari IK, Char DH, Verhey LJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:997-1010.
19. Karren KA, Kroll SM, Char DH, et al. Diabetic radiation morbidity. Br J Ophthalmol. 1992;76:61-62.
20. Gragoudas ES, Lane AM, Munzenrider JE, et al. Long-term risk of local failure after proton radiation for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002:100.
21. Char DH, Kroll S, Phillips TL, et al. Late radiation failures after I-125 brachytherapy for uveal melanoma compared with charged particle (proton or helium ion) therapy. Ophthalmology. 2002;109:1850-1854.
22. Char DH. Tumors of the Eye and Ocular Adnexa. BC Decker, Hamilton, Ontario 2001.
23. Rofstad EK, Henriksen K, Galappathi K, et al. Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts. Cancer Res. 2003;63:4055-4061.
24. Sonveaux P, Brouet A, Havaux X, et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 2003;63:1012-1019.
25. Ogata T, Teshima T, Kagawa K, et al. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;65:113-120.